APOL1-MEDIATED KIDNEY DISEASE
Clinical trials for APOL1-MEDIATED KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new APOL1-MEDIATED KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for APOL1-MEDIATED KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to plug leaky kidneys in APOL1 disease
Disease control Recruiting nowThis study tests an injectable drug called AZD2373 in 136 people with APOL1-mediated kidney disease, a genetic condition that mainly affects people of African descent. The goal is to see if the drug can reduce protein leakage into urine, a sign of kidney damage. Participants will…
Matched conditions: APOL1-MEDIATED KIDNEY DISEASE
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Blood test may flag hidden kidney disease risk before damage is done
Diagnosis Recruiting nowThis study tests a blood-based genetic test designed to identify people who carry two copies of high-risk APOL1 gene variants, which are linked to a type of kidney disease. Around 2,000 participants who are already being considered for a separate treatment trial will provide a bl…
Matched conditions: APOL1-MEDIATED KIDNEY DISEASE
Phase: NA • Sponsor: Almac Diagnostic Services LLC • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC